ANTI-VIRAL COMPOUNDS

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection. Se describen compuestos efectivos...

Full description

Saved in:
Bibliographic Details
Main Authors Sachin V. PATEL, John K. PRATT, Pamela L. DONNER, Clarence J. MARING, Charles W. HUTCHINS, Tammie K. JINKERSON, Danchun LIU, David A. DEGOEY, Mark A. MATULENKO, Charles A. FLENTGE, Yi GAO, Rolf WAGNER, William A. CARROLL, John T. RANDOLPH, Todd W. ROCKWAY, Allan C. KRUEGER, Kathy SARRIS, Ryan G. KEDDY, Douglas H. HUTCHINSON, David A. BETEBENNER, Kevin R. WOLLER, Warren M. KATI
Format Patent
LanguageEnglish
Spanish
Published 13.03.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection. Se describen compuestos efectivos para inhibir la replicación del virus de la Hepatitis C ("VHC"). Esta invención también se refiere a procedimientos para elaborar dichos compuestos, a composiciones que comprenden dichos compuestos, y a métodos para utilizar dichos compuestos para tratar infección por VHC.
Bibliography:Application Number: MX20130009763